✦ LIBER ✦
Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study
✍ Scribed by Jean Jacques Grob; Thomas Jouary; Brigitte Dréno; Julien Asselineau; Ralf Gutzmer; Axel Hauschild; Marie Thérèse Leccia; Michael Landthaler; Claus Garbe; Bruno Sassolas; Rudolf A Herbst; Bernard Guillot; Genevieve Chene; Hubert Pehamberger
- Book ID
- 119233339
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 406 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.